Canada markets closed

Eve & Co Incorporated (EVE.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.4600-0.0100 (-2.13%)
At close: 3:38PM EST
Full screen
Previous Close0.4700
Open0.5200
Bid0.4500 x 0
Ask0.4600 x 0
Day's Range0.4500 - 0.5200
52 Week Range0.2500 - 1.6500
Volume38,849
Avg. Volume115,293
Market Cap13.242M
Beta (5Y Monthly)1.32
PE Ratio (TTM)N/A
EPS (TTM)-0.3180
Earnings DateNov. 26, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.40
  • Eve & Co Completes First Shipment of Dried Flower Products to the Province of New Brunswick
    GlobeNewswire

    Eve & Co Completes First Shipment of Dried Flower Products to the Province of New Brunswick

    STRATHROY, Ontario, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (“Eve & Co” or the “Company”) (TSX-V: EVE; OTCQX: EEVVD) is pleased to announce that it has, through its wholly-owned subsidiary Natural MedCo Ltd. (“NMC”), successfully completed its first shipment of cannabis products to Cannabis NB. Eve & Co’s cannabis products will be available on Cannabis NB’s website (www.cannabis-nb.com) and can be purchased at licensed New Brunswick retailers. The first shipment consisted of Eve & Co’s new 28g dried flower products, available in Sativa Blend and Indica Blend. The cannabis flower in these new products is sun-grown in Southwestern Ontario, hang-dried, machine-trimmed and hand-finished to maintain optimal flavour and quality. “Our team has been working hard to expand our distribution within the Canadian market, and we are excited to be able to offer our new 28g cannabis flower products to New Brunswick. We are very happy to be working with the wonderful team at Cannabis NB and look forward to building a strong relationship”, said Melinda Rombouts, President and Chief Executive Officer of Eve & Co. New Brunswick is the fifth Canadian province into which the Company has supplied cannabis products. Eve & Co has plans to continue expanding distribution and product offerings throughout the Canadian adult-use market during 2021. ABOUT EVE & CO Eve & Co, through its wholly-owned subsidiary NMC, holds cultivation and processing licences under the Cannabis Act (Canada) for the production and sale of various cannabis products, including dried cannabis, cannabis plants and extraction of cannabis oil and has received its European Union certificate of Good Manufacturing Practice. NMC was Canada’s first female-founded licensed producer of medicinal marijuana and received its cultivation licence from Health Canada in 2016. Eve & Co is led by a team of agricultural experts and has a licensed 1,000,000 square foot greenhouse located in Strathroy, Ontario. The Company’s website can be visited at www.evecannabis.ca. Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Notice regarding forward looking statements: Certain statements in this press release constitute forward-looking information. All statements other than statements of historical fact contained in this press release, including, without limitation, those regarding the Company’s expected availability of its cannabis products in New Brunswick, opportunities for growth, future, strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words “believe”, “expect”, “aim”, “intend”, “plan”, “continue”, “will”, “may”, “would”, “anticipate”, “estimate”, “forecast”, “predict”, “project”, “seek”, “should” or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company’s expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict, including those described in the Company’s management’s discussion and analysis for the three and nine month periods ended September 30, 2020 which is available on the Company’s SEDAR profile. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. The forward-looking information and forward-looking statements included in this news release are made as of the date of this news release. The Company does not undertake an obligation to publicly update such forward-looking information or forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities law. For further information, please contact: Melinda RomboutsPresident and Chief Executive OfficerEve & Co IncorporatedTelephone: (855) 628-6337

  • Eve & Co Issues Corporate Update
    GlobeNewswire

    Eve & Co Issues Corporate Update

    STRATHROY, Ontario, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (“Eve & Co” or the “Company”) (TSX-V: EVE; OTCQX: EEVVD) announces a corporate update. As a result of the Company’s consolidation of its common shares (“Common Shares”) on a 1:10 basis as announced on December 29, 2020 (the “Consolidation”), the 4,581,500 share purchase warrants (the “Warrants”) of the Company issued together with the December 11, 2020 Convertible Debentures (being 0.833 Warrants for each Cdn$1.00 principal amount of those Convertible Debentures) have been proportionately adjusted such that following the Consolidation, each Warrant now entitles the holder to acquire one-tenth of one Common Share for a period of two years from the date of issuance of the Warrant, at an adjusted post-Consolidation exercise price of Cdn$0.60 per one (1) whole Common Share for the first year of the term, and Cdn$1.00 per one (1) whole Common Share for the second year of the term.In addition, the 20,900,000 share purchase warrants of the Company issued on May 10, 2019 (the “2019 Warrants”) have also been proportionately adjusted as a result of the Consolidation pursuant to which each 2019 Warrant now entitles the holder to acquire one-tenth of one Common Share until May 10, 2021, at an adjusted post-Consolidation exercise price of Cdn$6.00 per one (1) whole Common Share.The Company also announces the grant of 100,000 options to purchase Common Shares (the “Options”) to a director. The Options are exercisable at a price of Cdn$0.42 per share, for a term of five years. The terms of the Options granted on January 5th, 2020 are in accordance with the Company's stock option plan.ABOUT EVE & COEve & Co, through its wholly-owned subsidiary Natural MedCo Ltd (“NMC”), holds cultivation and processing licences under the Cannabis Act (Canada) for the production and sale of various cannabis products, including dried cannabis, cannabis plants and extraction of cannabis oil and has received its European Union certificate of Good Manufacturing Practice. NMC was Canada’s first female-founded licensed producer of medicinal marijuana and received its cultivation licence from Health Canada in 2016. Eve & Co is led by a team of agricultural experts and has a licensed 1,000,000 square foot greenhouse located in Strathroy, Ontario. The Company’s website can be visited at www.evecannabis.ca.The TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur, and include, but are not limited to, the negative of these words or other variations on these words or comparable terminology. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. Forward-looking statements contained in this release including statements with respect to the proposed use of proceeds of the financing and potential conversion/exercise of the Debentures and Warrants, amongst other matters. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements, including general business and economic conditions, changes in laws and regulations, product demand, changes in prices of required commodities, competition, the effects of and responses to the COVID-19 pandemic and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's management’s discussion and analysis dated November 26, 2020 (the "MD&A") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR at www.sedar.com. The Company cautions that the list of risks, uncertainties and other factors described in the MD&A is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. These forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law.For further information, please contact: Melinda Rombouts President and Chief Executive Officer Eve & Co Incorporated Telephone: (855) 628-6337Rory Taylor Interim Chief Financial Officer Eve & Co Incorporated Telephone: (855) 628-6337

  • Eve & Co Announces CAD$1M Private Financing
    GlobeNewswire

    Eve & Co Announces CAD$1M Private Financing

    STRATHROY, Ontario, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Eve & Co. Incorporated (TSXV: EVE) (OTCQX: EEVVF) (the “Company” or “Eve & Co”) announces that its wholly-owned subsidiary Natural MedCo Ltd (“NMC”) has entered into a CAD$1M financing loan with a private consortium of lenders (the “CAD$1M financing” or the “Loan”). The CAD$1M financing has a two-year term and is to be received in two equal tranches of CAD$500,000. The first CAD$500,000 tranche has been received – net of issuance costs of approximately CAD$29,000 – and bears interest – payable monthly – at 15% per annum for the first year and 11% per annum for the second year. Monthly repayments of principal and interest can only be made during the second year of the term. The principal outstanding will be repaid to the Lender at the end of the two-year term.The second CAD$500,000 tranche will be received from the Lender upon five days written request from NMC. It will bear interest – payable monthly – at 15% per annum for the first year and 11% per annum for the second year. Monthly repayments of principal and interest can only be made during the second year of the term. The principal outstanding will be repaid to the Lender at the end of the two-year term. The second CAD$500,000 tranche will only be available for the first year and a facility fee of 0.5% per annum on this second tranche will accrue – and be paid – monthly to the Lender. The Loan is secured by the assets of the Company and NMC and guarantees and is expected to be used for general corporate purposes.ABOUT EVE & CO INCORPORATED Eve & Co, through its wholly-owned subsidiary NMC, holds cultivation and processing licences under the Cannabis Act (Canada) for the production and sale of various cannabis products, including dried cannabis, cannabis plants and extracts and has received its European Union certificate of Good Manufacturing Practice which allows Eve & Co to distribute its products to the European Union. NMC was Canada’s first female-founded licensed producer of medicinal marijuana and received its cultivation licence from Health Canada in 2016. Eve & Co is led by a team of agricultural experts and has a licensed 1,000,000 square foot greenhouse located in Strathroy, Ontario. The Company’s website can be visited at www.evecannabis.ca.Forward-Looking StatementsThis news release contains certain forward-looking statements and forward-looking information (collectively referred to herein as "forward-looking statements") within the meaning of Canadian securities laws. Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur, and include, but are not limited to, the negative of these words or other variations on these words or comparable terminology. All statements other than statements of historical fact are forward-looking statements. Undue reliance should not be placed on forward-looking statements, which are inherently uncertain, are based on estimates and assumptions, and are subject to known and unknown risks and uncertainties (both general and specific) that contribute to the possibility that the future events or circumstances contemplated by the forward-looking statements will not occur. Although the Company believes that the expectations reflected in the forward-looking statements contained in this press release, and the assumptions on which such forward-looking statements are made, are reasonable, there can be no assurance that such expectations will prove to be correct. Forward-looking statements contained in this release including statements with respect to the proposed use of proceeds of the financing amongst other matters. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements, including general business and economic conditions, changes in laws and regulations, product demand, changes in prices of required commodities, competition, the effects of and responses to the COVID-19 pandemic and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's management’s discussion and analysis dated November 26, 2020 (the "MD&A") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR at www.sedar.com. The Company cautions that the list of risks, uncertainties and other factors described in the MD&A is not exhaustive and other factors could also adversely affect its results. Readers are cautioned not to place undue reliance on forward-looking statements included in this document, as there can be no assurance that the plans, intentions or expectations upon which the forward-looking statements are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause the Company's actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof and the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, except as required by applicable law. The forward-looking statements contained herein are expressly qualified by this cautionary statement.NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.For further information please contact:Melinda Rombouts President and Chief Executive Officer Eve & Co Incorporated Telephone: (855) 628-6337For further information please contact:Rory Taylor Interim Chief Financial Officer Eve & Co Incorporated Telephone: (855) 628-6337